Cite
Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis I
MLA
Alla Victoroff, et al. “Evaluation of Non-Reducing End Pathologic Glycosaminoglycan Detection Method for Monitoring Therapeutic Response to Enzyme Replacement Therapy in Human Mucopolysaccharidosis I.” Molecular Genetics and Metabolism, vol. 129, no. 2, June 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1c253bd3c2ec3870c0d797e8ea9969d6&authtype=sso&custid=ns315887.
APA
Alla Victoroff, Merry Passage, Jillian R. Brown, Moin Vera, Agnes Chen, Steven Q. Le, Patricia I. Dickson, Lynda E. Polgreen, & Brett E. Crawford. (2019). Evaluation of non-reducing end pathologic glycosaminoglycan detection method for monitoring therapeutic response to enzyme replacement therapy in human mucopolysaccharidosis I. Molecular Genetics and Metabolism, 129(2).
Chicago
Alla Victoroff, Merry Passage, Jillian R. Brown, Moin Vera, Agnes Chen, Steven Q. Le, Patricia I. Dickson, Lynda E. Polgreen, and Brett E. Crawford. 2019. “Evaluation of Non-Reducing End Pathologic Glycosaminoglycan Detection Method for Monitoring Therapeutic Response to Enzyme Replacement Therapy in Human Mucopolysaccharidosis I.” Molecular Genetics and Metabolism 129 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....1c253bd3c2ec3870c0d797e8ea9969d6&authtype=sso&custid=ns315887.